Netrin-1 and multiple sclerosis: a new biomarker for neuroinflammation?

Area of Science:

• Neuroscience
• Immunology
• Biochemistry

Background:

• Netrin-1 is an axon guidance protein that reduces inflammation and stabilizes the blood-brain barrier.
• Its role in central nervous system inflammatory diseases like multiple sclerosis (MS) is not fully understood.

Purpose of the Study:

• To investigate the presence and levels of netrin-1 in the experimental autoimmune encephalomyelitis (EAE) mouse model.
• To evaluate netrin-1 serum levels in multiple sclerosis (MS) patients with varying clinical activity.

Main Methods:

• Netrin-1 and tumor necrosis factor-alpha (TNFα) levels were measured in EAE mouse tissues and serum.
• Serum netrin-1 and TNFα were quantified in 90 MS patients and 30 controls using ELISA.
• Longitudinal evaluation of 10 relapsing-remitting MS patients during relapse was performed.

Main Results:

• EAE mice exhibited lower netrin-1 and higher TNFα levels compared to controls.
• MS patients showed significantly lower serum netrin-1 levels than controls (P ≤ 0.005).
• Lowest netrin-1 levels were observed in MS patients during relapse, with higher TNFα levels negatively correlated with netrin-1 (r = -0.3734, P ≤ 0.0001).

Conclusions:

• Netrin-1 levels decrease in EAE and MS, particularly during relapse, indicating an anti-inflammatory function.
• Netrin-1 may serve as a potential biomarker for MS inflammatory activity, warranting further investigation in larger cohorts.